Connection

Solange Peters to Infusions, Intravenous

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Infusions, Intravenous.
Solange Peters
Connection Strength
0.123
Infusions, Intravenous
  1. Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). J Clin Oncol. 2017 Aug 20; 35(24):2781-2789.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.